We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi plans to spend $3.2 billion to buy clinical-stage messenger-RNA (mRNA) therapeutics company Translate Bio, deepening its holdings in the mRNA space to develop new therapeutics and vaccines. Read More
The U.S. District Court for the Eastern District of Pennsylvania dismissed the case “with prejudice,” meaning that the court intends for the dismissal to be final in all courts. Read More
Teva Pharmaceuticals has sued Amicus Therapeutics, alleging the company refused to supply samples of its high-priced branded drug, Galafold (migalastat), as required under federal law. Read More